Sana Biotechnology Inc vs Tidewater Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Tidewater Inc trades at $78.18 (market cap $3.75B). The key difference: Tidewater Inc is far larger — about 4.3× Sana Biotechnology Inc's market cap, and Tidewater Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | TDW | |
|---|---|---|
Market Cap | $873.84M | $3.75B |
Sector | Health | Utilities |
52-Week High | $5.92 | $91.12 |
52-Week Low | $2.68 | $47.29 |
Enterprise Value | $848.03M | $3.85B |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →